![Cathal Friel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cathal Friel
Fondatore presso HVIVO PLC
Patrimonio netto: 14 M $ in data 31/05/2024
Profilo
Cathal Martin Friel founded hVIVO Ltd.
in 2020, where he is working as Non-Executive Chairman from 2020, Fastnet Equity Plc in 2011, where he worked as Executive Chairman from 2011 to 2014, Raglan Capital Ltd.
in 2007, where he is working as Managing Director from 2007, hVIVO PLC in 2011, where he is working as Non-Executive Chairman from 2022, Poolbeg Pharma Plc in 2020, where he is working as Executive Chairman from 2024, European Green Transition Plc in 2022, where he is working as Non-Executive Director from 2022, Amryt Pharma Holdings Ltd.
in 2004, where he worked as Non-Executive Director from 2015 to 2017, and Open Orphan DAC in 2017, where he worked as Chief Executive Officer.
Mr. Friel also founded Amryt Pharma Holdings Ltd.
and Fastnet Equity Plc, where he worked as Chairman.
Mr. Friel also currently works at PrEP Biopharm Ltd., as Director from 2020.
Mr. Friel also formerly worked at Venn Life Sciences Holdings Plc, as Non-Executive Chairman from 2018 to 2019, Fastnet Equity Plc, as Chairman, Merrion Stockbrokers Ltd., as Founding Director, and T5 Oil & Gas Ltd., as Non-Executive Director from 2013 to 2018.
Mr. Friel received his Masters Business Admin degree in 1990 from the University of Ulster.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
HVIVO PLC
3.11% | 08/04/2024 | 21 159 177 ( 3.11% ) | 7 M $ | 31/05/2024 |
POOLBEG PHARMA PLC
7.44% | 19/02/2024 | 37 219 757 ( 7.44% ) | 6 M $ | 31/05/2024 |
Posizioni attive di Cathal Friel
Società | Posizione | Inizio |
---|---|---|
HVIVO PLC | Fondatore | 01/02/2011 |
HVIVO PLC | Fondatore | 01/04/2020 |
POOLBEG PHARMA PLC | Fondatore | 01/09/2020 |
Raglan Capital Ltd.
![]() Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Amministratore Delegato | 01/01/2007 |
PrEP Biopharm Ltd.
![]() PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | Direttore/Membro del Consiglio | 10/07/2020 |
Precedenti posizioni note di Cathal Friel
Società | Posizione | Fine |
---|---|---|
T5 Oil & Gas Ltd.
![]() T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 09/08/2018 |
Amryt Pharma Holdings Ltd.
![]() Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Fondatore | 28/03/2017 |
Fastnet Equity Plc
![]() Fastnet Equity Plc Financial ConglomeratesFinance Fastnet Equity Plc engages in exploration of oil and gas. It operates through the following geographical segments: UK and Ireland; and Morocco. The company was founded in December 20, 2004 and is headquartered in Stockport, the United Kingdom. | Presidente | - |
Amryt Pharma Holdings Ltd.
![]() Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Fondatore | - |
░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ | - |
Formazione di Cathal Friel
University of Ulster | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
HVIVO PLC | Commercial Services |
POOLBEG PHARMA PLC | Health Technology |
Aziende private | 9 |
---|---|
Fastnet Equity Plc
![]() Fastnet Equity Plc Financial ConglomeratesFinance Fastnet Equity Plc engages in exploration of oil and gas. It operates through the following geographical segments: UK and Ireland; and Morocco. The company was founded in December 20, 2004 and is headquartered in Stockport, the United Kingdom. | Finance |
Raglan Capital Ltd.
![]() Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Finance |
Amryt Pharma Holdings Ltd.
![]() Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
T5 Oil & Gas Ltd.
![]() T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Energy Minerals |
Venn Life Sciences Holdings Plc
![]() Venn Life Sciences Holdings Plc Services to the Health IndustryHealth Services Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland. | Health Services |
Open Orphan DAC
![]() Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | Technology Services |
Merrion Stockbrokers Ltd.
![]() Merrion Stockbrokers Ltd. Investment Banks/BrokersFinance Part of Cantor Fitzgerald LP, Merrion Stockbrokers Ltd. is a brokerage firm that provides brokerage services. The company is based in Dublin, Ireland. The Irish company was founded in 1999. Johnny Lynch has been the CEO of the company since 2015. | Finance |
hVIVO Ltd.
![]() hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
PrEP Biopharm Ltd.
![]() PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | Health Technology |
- Borsa valori
- Insiders
- Cathal Friel